TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
Reports summarize tuberculosis research from University of Oxford
May 26th, 2009
"The need for an improved vaccine against tuberculosis has never been more urgent. The HIV epidemic and the emergence of multi and extensively drug-resistant strains of Mycobacterium tuberculosis mean that global control of this pathogen remains inadequate," scientists in Oxford, the United Kingdom report. "The existing vaccine, BCG, confers only variable protection against pulomonary disease. Exposure to environmental mycobacteria may contribute to this variability in protective efficacy. Protective immunity against Mycobacterium tuberculosis is dependant on a cell-mediated immune response. Boosting BCG with a subunit vaccine, and/or replacing BCG with an improved BCG...
Source: TB & Outbreaks Week (2009-05-26)
|
